TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $862,000 | -11.1% | 2,135 | 0.0% | 0.10% | -26.1% |
| Q2 2018 | $970,000 | +38.0% | 2,135 | 0.0% | 0.13% | +25.2% |
| Q1 2018 | $703,000 | -7.3% | 2,135 | 0.0% | 0.11% | +20.2% |
| Q4 2017 | $758,000 | -81.5% | 2,135 | -82.0% | 0.09% | -84.8% |
| Q3 2017 | $4,096,000 | -52.6% | 11,885 | -18.2% | 0.58% | -60.2% |
| Q2 2017 | $8,641,000 | +127.4% | 14,535 | +120.7% | 1.47% | +97.6% |
| Q1 2017 | $3,800,000 | -10.5% | 6,585 | 0.0% | 0.74% | -30.9% |
| Q4 2016 | $4,247,000 | – | 6,585 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 91,833,000 | $98,950,000 | 5.16% |
| Ferox Capital Management LP | 5,390,000 | $5,796,000 | 2.37% |
| INCOME RESEARCH & MANAGEMENT | 7,472,000 | $8,014,000 | 2.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 14,535 | $8,641,000 | 1.47% |
| Lombard Odier Asset Management (Europe) Ltd | 21,660,000 | $23,433,000 | 1.33% |
| SHENKMAN CAPITAL MANAGEMENT INC | 11,864,000 | $12,783,000 | 1.15% |
| MACKAY SHIELDS LLC | 18,887,000 | $20,335,000 | 0.86% |
| AEGON USA Investment Management, LLC | 4,000,000 | $4,290,000 | 0.84% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 32,751,000 | $35,196,000 | 0.67% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,067,000 | $6,522,000 | 0.24% |